MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 525954 | Name: PF-0713

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF 0713 is a GABAA receptor agonist. It is used as an intravenous sedative-hypnotic for general anaesthesia, procedural sedation, ICU sedation, chemotherapy.

Chemical Structure

PF-0713
PF-0713
CAS#1083093-47-3

Theoretical Analysis

MedKoo Cat#: 525954

Name: PF-0713

CAS#: 1083093-47-3

Chemical Formula: C14H22O

Exact Mass: 206.1671

Molecular Weight: 206.33

Elemental Analysis: C, 81.50; H, 10.75; O, 7.75

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
PF-0713; PF 0713; PF713.
IUPAC/Chemical Name
2,6-Bis((1R)-1-methylpropyl)phenol, (-)-
InChi Key
FHTGJZOULSYEOB-GHMZBOCLSA-N
InChi Code
InChI=1S/C14H22O/c1-5-10(3)12-8-7-9-13(14(12)15)11(4)6-2/h7-11,15H,5-6H2,1-4H3/t10-,11-/m1/s1
SMILES Code
OC1=C([C@H](C)CC)C=CC=C1[C@H](C)CC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 206.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Chitilian HV, Eckenhoff RG, Raines DE. Anesthetic drug development: Novel drugs and new approaches. Surg Neurol Int. 2013 Mar 19;4(Suppl 1):S2-S10. doi: 10.4103/2152-7806.109179. Print 2013. PubMed PMID: 23653886; PubMed Central PMCID: PMC3642742. 2: Sneyd JR, Rigby-Jones AE. New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth. 2010 Sep;105(3):246-54. doi: 10.1093/bja/aeq190. Epub 2010 Jul 21. Review. PubMed PMID: 20650920.